Methoxsalen
Back to searchMolecule Structure
Scientific Name
Methoxsalen
Description of the Drug
Methoxsalen is a furocoumarin used to treat psoriasis and vitiligo.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00553
http://www.drugbank.ca/drugs/DB00553
Brand Name(s)
8-mop, Deltasoralen, Meladinine, Methoxsalen, Oxsoralen, Oxsoralen-ultra, Puvasoralen-8, Uvadex
Company Owner(s)
Actavis Inc, Mallinckrodt Hosp Products Ip Ltd, Ani Pharmaceuticals Inc, Valeant Pharmaceuticals International, Strides Pharma Global Pte Ltd, Bausch Health Americas Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL19168 | |||
| PharmGKB | PA450433 | |||
| Human Metabolome Database | HMDB0014693 | |||
| DrugBank | DB00553 | |||
| PubChem: Thomson Pharma | 14822550 | |||
| PubChem | 4114 | |||
| Mcule | MCULE-2500932325 | |||
| NMRShiftDB | 60015798 | |||
| LINCS | LSM-3410 | |||
| Nikkaji | J2.983A | |||
| PDBe | 8MO | |||
| BindingDB | 50041234 | |||
| EPA CompTox Dashboard | DTXSID8020830 | |||
| DrugCentral | 30 | |||
| Metabolights | MTBLC18358 | |||
| Brenda | 7629 | 144111 | 30509 | 246271 |
| Rhea | 18358 | |||
| ChemicalBook | CB6733540 | |||
| rxnorm | UVADEX | OXSORALEN | METHOXSALEN | |
| KEGG Ligand | C01864 | |||
| ChEBI | 18358 | |||
| ZINC | ZINC000002548959 |
